Experimental Knee Osteoarthritis Drug LRX712 Demonstrates Tolerability in Early Human Trial
A randomized first-in-human trial of intra-articular LRX712 in 42 patients with mild-to-moderate knee osteoarthritis showed acceptable tolerability and pharmacokinetics supporting ...



















